UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
2014
Video Recording
2014, ISBN 9780444594242, xvi, 407
Book
2017, Communication and society, ISBN 1315622289, xvii, 200 pages
Book
2017, Erste Aufl. 2017, Originalausg., Suhrkamp Taschenbuch, ISBN 3518467697, Volume 4769, 252
Book
国际脑血管病杂志, ISSN 1673-4165, 2012, Volume 20, Issue 2, pp. 85 - 124
Journal Article
2006, ISBN 1555813062, xii, 442
Book
2014, ISBN 9783897858350, 228
Book
1997, Routledge history of world philosophies, ISBN 9780415080644, Volume 2, xii, 934
Book
2012, ISBN 9783865301727, 143
Book
2016, Strüngmann Forum reports, ISBN 0262035421, xii, 408 pages
Book
2011, 12th ed., McGraw-Hill's AccessMedicine, ISBN 0071624422, 2047
eBook
2016, 1st edition., APA handbooks in psychology, ISBN 9781433819698, xxiv, 626
Book
2015, Cambridge astrobiology, ISBN 1107073650, Volume 8, xxii, 319
Book
The New England journal of medicine, ISSN 0028-4793, 12/2016, Volume 375, Issue 26, pp. 2519 - 2529
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Celecoxib - adverse effects | Naproxen - adverse effects | Ibuprofen - therapeutic use | Humans | Middle Aged | Male | Risk | Celecoxib - therapeutic use | Naproxen - therapeutic use | Cyclooxygenase 2 Inhibitors - adverse effects | Anti-Inflammatory Agents, Non-Steroidal - adverse effects | Anti-Inflammatory Agents, Non-Steroidal - therapeutic use | Arthritis - drug therapy | Cyclooxygenase 2 Inhibitors - therapeutic use | Intention to Treat Analysis | Kidney Diseases - chemically induced | Cardiovascular Diseases - mortality | Female | Aged | Cardiovascular Diseases - chemically induced | Ibuprofen - adverse effects | Gastrointestinal Diseases - chemically induced | Care and treatment | Safety and security measures | Naproxen | Ibuprofen | Dosage and administration | Arthritis | Celecoxib | Diagnosis | Cardiovascular diseases | Risk factors | Cardiovascular disease | Side effects | Nonsteroidal anti-inflammatory drugs | Pain management | Myocardial infarction | Fees & charges | Hemorrhage | Pain | Motivation | Analgesics | Safety | Drug dosages | Cerebral infarction | Statistical analysis | Anemia | Committees | FDA approval | Patients | Manuscripts | Rheumatoid arthritis | Collaboration | Osteoarthritis | Pharmaceuticals | Index Medicus | Abridged Index Medicus
Journal Article